Drug Profile
Cytochalasin B
Alternative Names: Biostent; PreverexLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Poniard Pharmaceuticals
- Class Indoles; Macrolides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis